Big shift in policy
On the eve of World aids Day (December 1), Union health minister Sushma Swaraj announced that aids medicine would be made available through the national aids control programme from next year. The plan hinges crucially on an agreement with the Indian generic drug industry to supply medicines cheap. Indeed, companies have sought assurances on sales volumes and tax concessions on certain imports used to make the drugs. "It will be the focus of the ministry's pre-budget exercise and if the finance minister and Planning Commission agree, we hope to make medicine available from April 1, 2004,' Swaraj said.
A spokesperson for New Delhi-based Ranbaxy Laboratories said if the government slashed various taxes, the cost of drugs could fall to Rs 15.90, the cheapest in the world.
Swaraj's announcement also signals a major shift in the country's aids policy
Related Content
- Mapping India's energy policy 2023: a decade in action
- How can India scale up electricity demand-side management? insights from a multi-state assessment of DSM regulations and Discom action
- E-bikes: charging toward compact cycling cities
- Used heavy- duty vehicles and the environment: a global overview of used heavy-duty vehicles- flow, scale and regulation
- Gendered prevalence of non-communicable diseases in India’s older adults
- Revamping water governance in India: the pathway to a new national water policy